Aims Histopathological tissue samples are being increasingly used as sources of nucleic acids in molecular pathology translational research. This study investigated the suitability of glioblastoma and control central nervous system (CNS) formalin-fixed paraffin embedded (FFPE) tissue-derived RNA for gene expression analyses. Methods Total RNA was extracted from control (temporal lobe resection tissue) and glioblastoma FFPE tissue samples. RNA purity (260/280 ratios) was determined and RNA integrity number (RIN) analysis was performed. RNA was subsequently used for RT-qPCR for two reference genes, 18S and GAPDH.
Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays
InTrOduCTIOn
Gliomas are the most common primary central nervous system (CNS) tumours, with an incidence of 6.6 per 100 000 individuals per year. 1 Approximately 50% of newly diagnosed gliomas are glioblastomas. 2 The median patient survival is approximately 15 months in the setting of a clinical trial 3 4 and only 12 months using the current established treatment regimens. 1 5 Histopathological diagnosis of glioblastoma is dependent on formalin-fixed paraffin embedded (FFPE) tissue obtained from a biopsy or surgical resection. Despite a number of practical issues regarding using this diagnostic tissue for research, the number of molecular studies incorporating FFPE material is increasing. 6 The high-quality morphological information that FFPE tissue provides facilitates accurate macrodissection and microdissection of areas of interest. This means that with downstream nucleic acid purification and enrichment, histopathological abnormalities (e.g. the malignant transformation of a cellular population or subpopulation) can be interrogated using molecular tools. 7 This approach has been widely used in the discovery phase of biomarker investigation for large-scale validation and for subsequent implementation into routine clinical practice. 8 Tumour tissue is a heterogeneous milieu of non-transformed cells, immune cells, stromal cells and areas of necrosis in which the neoplastic cells may only represent a small proportion. Therefore, accurate assessment of tumour cell composition by expert histopathologists based on morphological features is essential. This assessment can then guide nucleic acid extraction for subsequent molecular analyses. This may be done manually using premarked H&E sections to guide the dissection of areas of tissue (i.e., macrodissection) or using automated laser capture microdissection, 9 with the emerging possibility of single cell analysis. 10 Techniques such as expression microdissection may allow for enrichment of extracted cell populations by immunohistochemical labelling. 11 In contrast, the use of fresh-frozen (unfixed) tissue is associated with the homogenisation of tissue samples (for downstream protein, DNA or RNA extraction), a bulk analysis approach in which the input cellular material may be suboptimally (or blindly) selected.
RNA isolated from FFPE tissue is often of lower quality than that obtained from fresh-frozen tissue, frequently showing evidence of degradation, fragmentation and reduced assay efficiency. 12 Nucleic acid quantity and quality may also be dependent on the extraction method used. 13 14 It is therefore important that RNA extracted from FFPE samples is adequately assessed before being assayed in downstream molecular applications.
This study examined the applicability of FFPE tissue for total RNA extraction for subsequent molecular expression analyses in the context of glioblastoma. Quality control (QC) metrics were Original article assessed for FFPE tissue-derived RNA for glioblastoma and (control) epilepsy resection specimens.
MATerIAls And MeThOds study samples
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wild-type (primary) glioblastoma FFPE surgical specimens, 15 diagnosed according to WHO diagnostic criteria, were obtained from the Brain Tumour Bank Southwest, UK. FFPE tissue samples from histologically normal anterior temporal lobe surgical resections were used as controls.
Tumour FFPe sample area selection for macrodissection
Two histopathologist researchers (HRH and KMK) reviewed H&E-stained FFPE glioblastoma sections and marked areas containing only tumour cells. Any areas containing extensive tissue necrosis, haemorrhage, microvascular proliferation or histologically normal cerebral cortex were marked for exclusion from downstream total RNA extraction.
rnA extraction from FFPe tissue sections
Tissue blocks were sectioned at 5 µm and stored in the absence of light at ambient temperature for a maximum of 21 days. Total RNA was extracted from either whole control tissue (n=17; ×10 5 µm FFPE unstained sections) or macrodissected regions of glioblastoma tissue (n=48; ×10 5 µm FFPE unstained sections). Total RNA was extracted using an EZNA FFPE RNA kit (Omega Bio-tek) including a gDNA elimination spin column step, as previously described. 16 Purified total RNA was eluted into RNase-free water. RNA was stored at −80°C until use.
rnA quality and quantity
RNA concentration and 260/280 ratios were determined using a Nanodrop 1000 UV spectrophotometer (Thermo Scientific). RNA integrity number (RIN) analysis was performed using an Agilent 2100 Bioanalyser and RNA 6000 LabChip kit with Agilent 2100 Expert software (Agilent Technologies). 260/280 ratios and RIN were determined for all control samples (n=17) and a subset of glioblastoma samples (selected randomly, n=29). Two RIN values were not detected using the Agilent 2100 instrument in the glioblastoma cohort. Total RNA was reverse transcribed to cDNA using a Clontech TaKaRa PrimeScript first strand cDNA Synthesis Kit (TaKaRa Bio) following the manufacturer's protocol.
linear dynamic range and efficiency of quantitative reverse transcription PCr (rT-qPCr) reactions
The linear dynamic range (LDR) for each Taqman assay on demand (AOD) was investigated prior to gene expression analyses. Taqman Fast Gene Expression Master Mix (Applied Biosystems) was used. The LDR of each AOD was assessed using a standard curve method, using serial dilutions of cDNA template. The log of cDNA starting quantity against the cycle threshold (C t ) value obtained during amplification was plotted for each dilution. Experiments were performed in triplicate using the StepOnePlus Real-Time PCR system and StepOne software V.2.1 (Applied Biosystems), which provided an automated output to fit the equation of the linear regression line and the coefficient of determination (R 2 ). Two representative cDNA samples from each of the control and glioblastoma subsets of the FFPE cohort were used for this optimisation.
real-time rT-qPCr
RT-qPCR was performed with a StepOnePlus instrument with Taqman Fast Gene Expression Master Mix (both Applied Biosystems) and AOD gene expression products for GAPDH (Hs02758991_g1) (amplicon length, 93 bp) and 18S (Hs03003631_g1) (amplicon length, 69 bp) (Taqman MGB probes, FAM dye labelled; Applied Biosystems). Experiments were performed in triplicate. Relative gene expression was analysed with the 2 -ΔΔCt method 17 and the geomean was calculated for each group. No template control (1 µL nuclease-free water) and RT-template (gDNA contamination) control samples were included in each PCR run. The amplification baseline and threshold were automatically calculated by the StepOne software.
statistical analysis
Data normality was tested using the Kolmogorov-Smirnov and the D'Agostino and Pearson omnibus normality tests. A MannWhitney U test or unpaired t-test was used to compare the parameters RIN, age of block and 260/280 ratios in control versus disease tissue. Correlation analysis was performed using Pearson correlation coefficient (parametric data) or Spearman's rank correlation (non-parametric data) as appropriate. All statistical tests were two tailed. Differences at p<0.05 were considered statistically significant. Statistical tests were performed using GraphPad Prism V.5 for Windows (GraphPad).
resulTs
The ldr of rT-qPCr AOd
AOD optimisation was performed for the reference genes GAPDH and 18S by generating a standard curve prior to downstream quantification of relative gene expression. The R 2 for both GAPDH and 18S was >0.980 ( figure 1A ,B), indicative of a strong linear relationship between absolute starting template and assay output. Downstream relative gene expression studies were performed using RT-qPCR and starting cDNA concentrations corresponding to the median cDNA concentration within the LDR for each AOD.
reference gene expression in control versus glioblastoma FFPe tissue
RT-qPCR was performed on cDNA generated from FFPE control and glioblastoma tissue blocks. There was no significant difference in the expression of the reference gene GAPDH in the glioblastoma samples compared with control samples when normalised to 18S mRNA expression (p=0.576; figure 2A) . Similarly, there was no significant difference in the expression of the reference gene 18S in glioblastoma samples compared with control samples, when normalised to GAPDH (p=0.575; figure 2B ).
Analysis of rnA QC metrics in control and glioblastoma FFPe tissue samples
The mean RIN in the control FFPE tissue cohort was 2.2 (range: 1.3-2.7). The mean RIN in the glioblastoma FFPE tissue cohort was 1.7 (range: 1.0-2.7). There was a significant difference in the RIN value between these two groups (p=0.008) (figure 3A). The mean age of the blocks (months) in the control cohort was 24.9 (range: 3-60). The mean age of the blocks (months) in the glioblastoma cohort was 32.9 (range: 14-55). There was no significant difference in the age of the blocks between these two groups (p=0.097) (figure 3B). The mean 260/280 ratio in the control cohort was 1.94 (range: 1.63-2.05). The mean 260/280 There was no significant difference in the 260/280 ratio between these two groups (p=0.715) ( figure 3C ). The mean percentage tumour (by area of total tissue per slide) in the glioblastoma FFPE tissue cohort alone was 61% (range: 15%-100%).
There was no statistically significant correlation between total RNA yield (ng/μL) versus RIN in the control and glioblastoma FFPE tissue blocks as a single group (p=0.250) (figure 4A). Furthermore, there was no statistically significant correlation between total RNA yield (ng/μL) versus 260/280 ratio in the control and glioblastoma FFPE tissue blocks as a single group (p=0.172) (figure 4B).
There was no significant correlation between age of the block versus RIN in the control or glioblastoma FFPE tissue blocks (p=0.249 and p=0.983, respectively) (figure 5A,B) and no significant correlation between age of the block versus total RNA yield (ng/μL) in the control or glioblastoma FFPE tissue blocks (p=0.268 and p=0.252, respectively) ( figure 5C,D) , although a non-significant overall negative trend was noted, particularly for the glioblastoma FFPE tissue blocks. There was no significant correlation between age of the block versus 260/280 ratios in the control or glioblastoma FFPE tissue blocks (p=0.384 and p=0.133, respectively) ( figure 6A,B) .
There was no significant correlation between RIN versus (raw) mean C t values for GAPDH or 18S mRNA expression values in the control and glioblastoma FFPE tissue blocks combined (p=0.119 and p=0.057, respectively) ( figure 7A,B) , although a non-significant overall negative trend was noted, particularly for mean 18S mRNA expression values ( figure 7B ). There was a statistically significant negative correlation between Original article (A and b) . RIN, RNA integrity number.
260/280 ratios versus (raw) mean C t values for GAPDH and 18S
mRNA expression values in the control and glioblastoma FFPE tissue blocks combined (p=0.013 and p=0.006, respectively) ( figure 7C,D) .
dIsCussIOn
It is essential that new tools are developed that better delineate the biological variants of glioblastoma. However, to date, molecular assays that determine which patients with newly diagnosed glioblastoma may respond to standard or experimental adjuvant therapies have proven elusive. Without a more finessed approach, treatment targets may be missed and patients given toxic therapies not sufficiently targeted to their tumour subtype. 18 In addition, molecular profiling can facilitate the identification of personalised prognostic features which can be used for patient stratification in clinical trial design, to ensure balance in the arms of randomised controlled trials of novel glioblastoma therapies. 19 Although data from targeted gene panel massive parallel sequencing approaches are already used to guide clinical decision-making at molecular tumour boards, 20 RNA expression analysis is likely to continue to have significant utility, complementing high-throughput sequencing of gDNA. 21 22 Gene expression studies have traditionally been carried out on nucleic acids extracted from fresh (snap) frozen tissue. More recently, however, FFPE tissue is being increasingly used due to its abundance in clinical diagnostic pathology archives and a growing interest in how to best control for the limitations inherent in FFPE-based genetic studies. [23] [24] [25] For example, the Oncotype DX clinical assay, which uses FFPE-derived RNA in RT-qPCR applications, is routinely used to guide adjuvant treatment decisions for patients with breast cancer. 26 This use of RNA expression analysis adds predictive value to established clinicopathological and protein expression variables and is applicable to routinely available FFPE specimens. Although similar approaches have been investigated for glioblastoma, 27 28 to date none have been extensively cross-validated or achieved widespread acceptance. In order for this powerful approach to be more widely implemented, a better understanding of the limiting factors in the molecular investigation of FFPE glioblastoma (and control) tissue-derived nucleic acids is required. In this study, the quality and quantity of RNA extracted from glioblastoma and control FFPE tissue were examined. Normalisation of RT-qPCR data to GAPDH or 18S is commonly used in gene expression studies, as their expression is considered to be ubiquitous in the entire cell population present in a tissue sample. This study demonstrated that there was no significant difference between GAPDH and 18S mRNA expression between control and glioblastoma samples, strongly suggesting that their expression is consistent between the two tissue cohorts. This is an important consideration when selecting reference genes for biological normalisation to perform quantitative mRNA studies comparing CNS tissue cohorts 29 30 and requires further cross validation with independent tissue sources.
During the optimisation of AOD used for downstream RT-qPCR analysis, GAPDH and 18S reference genes both returned high regression coefficient variables, suggesting low variability between technical replicates and indicating that the Original article PCR amplification efficiency was the same regardless of the starting template copy number. This is appropriate for studies on RNA extracted from FFPE tissue where the starting template amount may vary.
In this study, a single RNA FFPE extraction kit and protocol was used to extract total RNA from both primary glioblastoma and histologically normal anterior temporal lobe surgical resection samples derived from a single diagnostic archive. QC metrics were applied to the extracted total RNA prior to reverse transcription. Glioblastoma surgical samples that were subjected to RIN analysis had significantly lower RIN values compared with control tissue. It is likely that the lower RIN values obtained for the glioblastoma cohort occurred due to increased levels of apoptosis and necrosis occurring in the tumour tissue. Although substantial RNA degradation was noted, the mean RIN and RIN range was comparable to that found in previously published studies which used RNA extracted from FFPE tissue samples, both for human glioma samples 31 32 and other common cancers. 13 33 It is increasingly recognised that low RIN values (i.e. 1.0) do not preclude successful outcomes in gene expression studies. 34 35 The RIN and 260/280 ratios, pooled across both control and glioblastoma FFPE tissue blocks, showed no significant correlation with total RNA yield, suggesting that neither fragmentation of extracted RNA nor its purity impacted on downstream quantity measurements. This is in keeping with previous reports which suggest that the quality and quantity of RNA extracted from FFPE tissues are likely to be independent factors: RNA quality being affected primarily by preanalytical factors and RNA quantity by the extraction technique employed. 36 This effect has also been reported in snap-frozen CNS tissue (non-neoplastic) cohorts. 37 In both control and glioblastoma tissues, RIN values did not correlate significantly with the age of the blocks, a finding in keeping with previously published work on FFPE breast carcinoma samples. 33 Similarly, both total RNA yield and 260/280 ratios were not found to be correlated with the age of the tissue blocks. This has important implications for future investigations which may use retrospective FFPE tissue cohorts for translational molecular studies in which longer clinical follow-up is required.
There was no significant correlation between RIN values and raw C t values obtained for the reference genes GAPDH and 18S, in keeping with previous findings. 38 It is noteworthy that 260/280 ratios did, however, show a negative correlation with raw GAPDH and 18S C t values. A 260/280 ratio of 2.0 is widely accepted as 'pure' for RNA samples 39 : the lower values noted in this study are likely to be due to contamination by materials present in the FFPE sections or reagents used during RNA extraction from the FFPE tissue. The increasing raw C t values noted to correlate with the lower 260/280 ratios may have occurred due to a decrease in PCR amplification efficiency by inhibitory contaminants. This effect is predicted to occur for both any putative genes of interest and the reference genes described herein and is therefore less likely to influence downstream relative gene expression outputs.
In summary, this study showed that routinely available FFPE CNS tissue samples are suitable for RNA extraction and downstream gene expression studies, even after 60 months of storage. It was shown that substantial RNA fragmentation associated with glioblastoma and control cortex FFPE tissue blocks does not preclude successful downstream RT-qPCR gene expression analyses. Cross validation with both archival and prospectively collated FFPE specimens is required to further demonstrate that CNS tissue blocks can be used in novel translational molecular biomarker studies.
Take home messages
► Careful quality control of nucleic acids extracted from formalin-fixed paraffin embedded (FFPE) tissues is key to successful molecular analyses. ► Prolonged FFPE tissue storage may not affect the quality or quantity of RNA extracted. ► Substantial RNA fragmentation associated with FFPE tissue does not influence quantitative outputs in appropriately designed RT-qPCR analyses.
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